UK-based healthtech platform MANUAL has officially acquired FORMEL SKIN, Germany’s largest digital dermatology provider, in a landmark deal poised to create one of Europe's fastest-growing healthtech groups. This strategic union is driven by a shared vision to build a leading global platform for unified health, moving beyond single-specialty care. The first major initiative under this new partnership will be the launch of Germany's most advanced medical weight-loss program under the new brand name VOY.
A Strategic Union in European Healthtech
Since its inception in 2019, FORMEL SKIN has established itself as a dominant force in digital healthcare, delivering over two million treatments to tens of thousands of monthly users. The company’s success is built on a model that provides expert guidance and personalized treatments, achieving over 90 percent improvement in patient outcomes. This proven track record and deep medical expertise made it a highly valuable partner for MANUAL’s expansion plans.
Headquartered in Berlin with a team of 125 employees, FORMEL SKIN has become a trusted name by bridging the gap between medical professionals and patients at home. Through key partnerships with leading European universities, the company has consistently set the standard for digital dermatological care. This acquisition allows MANUAL to integrate this specialized knowledge and patient trust into its broader platform, accelerating its mission across new markets and conditions.
Expanding the Vision for Integrated Healthcare
The merger is founded on the principle that health conditions are often interconnected, a reality that fragmented digital services fail to address. The leadership of both companies recognized that issues like skin problems rarely exist in isolation and are frequently linked to hormones, hair loss, or weight. This partnership aims to create a seamless patient journey that reflects the true, holistic nature of personal health and well-being.
Florian Semler, Founder and CEO of FORMEL SKIN, called the acquisition the most important milestone in the company's history, marking a transition from a specialized provider to a comprehensive health platform. "For six years, we’ve been on a mission to make dermatology more accessible," Semler stated. "Together with MANUAL, we are excited to go beyond dermatology and build the world’s leading global health platform."
Introducing VOY: A New Frontier in Medical Weight Management
The first major initiative from the newly combined entity will be the launch of VOY, a new brand set to introduce Germany’s most advanced medical weight loss program. This program is designed to offer a comprehensive solution that combines clinically proven treatments with robust behavioral and lifestyle support. The goal is to empower patients to achieve and maintain long-term health outcomes through a medically supervised and personalized approach.
George Pallis, Founder and CEO of MANUAL, expressed his deep admiration for FORMEL SKIN's achievements and its significant growth potential. This enthusiasm is being channeled directly into the launch of VOY, which serves as the first concrete step in their joint mission. The new program exemplifies their shared commitment to expanding services and addressing a wider spectrum of health needs under one unified and powerful vision.
The acquisition of FORMEL SKIN by MANUAL represents a significant consolidation in the European healthtech sector, creating a powerful new group with ambitious global goals. By integrating deep dermatological expertise with a broader platform for holistic care, the company is well-positioned to redefine the digital patient experience. The imminent launch of the VOY weight-loss program is a clear signal of its intent to build a truly comprehensive and unified health platform for the future.